These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 24423028

  • 1. Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion.
    Rahman Z, Xu X, Katragadda U, Krishnaiah YS, Yu L, Khan MA.
    Mol Pharm; 2014 Mar 03; 11(3):787-99. PubMed ID: 24423028
    [Abstract] [Full Text] [Related]

  • 2. Comment on "Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion".
    Gore A, Attar M, Pujara C, Neervannan S.
    Mol Pharm; 2014 Jul 07; 11(7):2490-2. PubMed ID: 24803420
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case.
    Qu H, Wang J, Wu Y, Zheng J, Krishnaiah YSR, Absar M, Choi S, Ashraf M, Cruz CN, Xu X.
    Int J Pharm; 2018 Mar 01; 538(1-2):215-222. PubMed ID: 29341918
    [Abstract] [Full Text] [Related]

  • 5. Product Quality Research for Developing and Assessing Regulatory Submissions for Generic Cyclosporine Ophthalmic Emulsions.
    Belenos A, Wood EL, Hu M, Kozak D, Xu X, Fisher AC.
    AAPS J; 2023 Jan 26; 25(1):20. PubMed ID: 36702976
    [Abstract] [Full Text] [Related]

  • 6. Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time.
    Walenga RL, Babiskin AH, Zhang X, Absar M, Zhao L, Lionberger RA.
    J Pharm Sci; 2019 Jan 26; 108(1):620-629. PubMed ID: 30385283
    [Abstract] [Full Text] [Related]

  • 7. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions.
    Chennell P, Delaborde L, Wasiak M, Jouannet M, Feschet-Chassot E, Chiambaretta F, Sautou V.
    Eur J Pharm Sci; 2017 Mar 30; 100():230-237. PubMed ID: 28131754
    [Abstract] [Full Text] [Related]

  • 8. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.
    Xu X, Al-Ghabeish M, Rahman Z, Krishnaiah YS, Yerlikaya F, Yang Y, Manda P, Hunt RL, Khan MA.
    Int J Pharm; 2015 Sep 30; 493(1-2):412-25. PubMed ID: 26231106
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: Process optimization through response surface methodology (RSM) and biocompatibility evaluation.
    Li Y, Guan Q, Xu J, Zhang H, Liu S, Ding Z, Wang Q, Wang Z, Liu M, Zhao Y.
    Colloids Surf B Biointerfaces; 2023 May 30; 225():113267. PubMed ID: 36940502
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM, McGwin G, Liu B, Owsley C, Rosenstiel C.
    Eye Contact Lens; 2008 Jan 30; 34(1):43-5. PubMed ID: 18180683
    [Abstract] [Full Text] [Related]

  • 11. Understanding drug distribution and release in ophthalmic emulsions through quantitative evaluation of formulation-associated variables.
    Dong Y, Hengst L, Hunt R, Patel D, Vo A, Choi S, Ashraf M, Cruz CN, Xu X.
    J Control Release; 2019 Nov 10; 313():96-105. PubMed ID: 31536731
    [Abstract] [Full Text] [Related]

  • 12. A quality by design approach to optimization of emulsions for electrospinning using factorial and D-optimal designs.
    Badawi MA, El-Khordagui LK.
    Eur J Pharm Sci; 2014 Jul 16; 58():44-54. PubMed ID: 24704153
    [Abstract] [Full Text] [Related]

  • 13. Formulation characteristics and in vitro release testing of cyclosporine ophthalmic ointments.
    Dong Y, Qu H, Pavurala N, Wang J, Sekar V, Martinez MN, Fahmy R, Ashraf M, Cruz CN, Xu X.
    Int J Pharm; 2018 Jun 10; 544(1):254-264. PubMed ID: 29684560
    [Abstract] [Full Text] [Related]

  • 14. Analytical considerations for measuring the globule size distribution of cyclosporine ophthalmic emulsions.
    Petrochenko PE, Pavurala N, Wu Y, Yee Wong S, Parhiz H, Chen K, Patil SM, Qu H, Buoniconti P, Muhammad A, Choi S, Kozak D, Ashraf M, Cruz CN, Zheng J, Xu X.
    Int J Pharm; 2018 Oct 25; 550(1-2):229-239. PubMed ID: 30125649
    [Abstract] [Full Text] [Related]

  • 15. Quality by design approach to understand the process of nanosuspension preparation.
    Verma S, Lan Y, Gokhale R, Burgess DJ.
    Int J Pharm; 2009 Jul 30; 377(1-2):185-98. PubMed ID: 19446617
    [Abstract] [Full Text] [Related]

  • 16. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
    Rodriguez-Aller M, Kaufmann B, Guillarme D, Stella C, Furrer P, Rudaz S, El Zaoui I, Valamanesh F, Di Tommaso C, Behar-Cohen F, Veuthey JL, Gurny R.
    Eur J Pharm Biopharm; 2012 Apr 30; 80(3):544-52. PubMed ID: 22155591
    [Abstract] [Full Text] [Related]

  • 17. Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion.
    Deng Y, Zhong G, Wang Y, Wang N, Yu Q, Yu X.
    Int J Pharm; 2019 Nov 25; 571():118717. PubMed ID: 31610279
    [Abstract] [Full Text] [Related]

  • 18. Three generations of cyclosporine a formulations: an in vitro comparison.
    Thomas K, Koelwel C, Machei U, Färber L, Göpferich A.
    Drug Dev Ind Pharm; 2005 May 25; 31(4-5):357-66. PubMed ID: 16093201
    [Abstract] [Full Text] [Related]

  • 19. Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A.
    Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA.
    J Pharm Sci; 2007 Sep 25; 96(9):2409-23. PubMed ID: 17628495
    [Abstract] [Full Text] [Related]

  • 20. Investigation of different emulsion systems for dermal delivery of nicotinamide.
    Tuncay S, Özer Ö.
    Pharm Dev Technol; 2013 Sep 25; 18(6):1417-23. PubMed ID: 23742727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.